This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Kids are outsmarting social media bans. That’s not a problem we need to solve. —Michal Luria, Aliya Bhatia, and Danah Boyd Social media bans are stacking up. In July, France joined…
As experts have warned for the last two years, some companies — like Microsoft and now Google — are finding and patching an exponential number of bugs in their products, thanks to the use of LLMs and AI tools.
LinkedIn is introducing new ways to reduce low-quality AI-generated posts, including a “seems like AI slop” reporting option. It’s also replacing its own AI writing feature with a proofreading tool.
Financial planning gets all the attention in a business sale — but the identity, community and sense of purpose you lose the day you sign are what most founders never prepare for, and what defines whether the exit was actually worth it.
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…